Novo Nordisk Forges Ahead with Oral Wegovy and Weekly Insulin Amid CagriSema Device Study Withdrawal
Novo Nordisk is executing a multi-front strategy to defend its dominance in the obesity and diabetes markets, rolling…
Novo Nordisk Forges Singapore Weight-Loss Alliance as US Pricing Reset and Buyback Program Diverge
Novo Nordisk partners with NOVI Health in Singapore, cuts US GLP-1 prices, and continues buybacks as stock dips…